Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px

Product › Details

follitropin alpha (INN v)

	Next higher product group	anterior pituitary lobe hormone or analogue
	Status	1995-10-20 registration start
	Status	1997-01-01 sales existent
	Organisation	Ares-Serono (Europe) Ltd.
	Today	Serono Europe Ltd.
	Group	Merck (DE) (Group)

Record changed: 2023-07-10

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x200px

More documents for pharmaceutical

[1] Recipharm AB. (6/8/26). "Press Release: Recipharm and Fusix Biotech Advance Novel Oncolytic Virus Platform". Darmstadt....
[2] Roche. (6/8/26). "Press Release: Roche Announces Global Collaboration with Nurix Therapeutics to Co-develop and Co-commercialise Potential Best-in-class BTK Degrader". Basel....
[3] Ona Therapeutics S.L.. (6/4/26). "Press Release: Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development". Barcelona....
[4] H. Lundbeck A/S. (6/3/26). "Press Release: Lundbeck Partners with Cradle to Discover and Optimize Brain Disorder Treatments". Valby & Amsterdam....
[5] DaltonTx Ltd.. (5/27/26). "Press Release: Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics". Waltham, MA & London....
[6] LimmaTech Biologics AG. (5/26/26). "Press Release: LimmaTech Biologics to Be Acquired by Lilly for Next-generation Vaccines Against Common Bacterial Infections". Schlieren....
[7] Eli Lilly and Company. (5/26/26). "Press Release: Lilly Announces Three Acquisitions to Build Infectious Disease Portfolio". Indianapolis, IN....
[8] Nanobiotix S.A.. (5/21/26). "Press Release: Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering". Paris & Cambridge, MA....
[9] InSphero AG. (5/20/26). "Press Release: InSphero Accelerates Global Growth and US Expansion with Acquisition of PhenoVista Biosciences". Schlieren....
[10] Haya Therapeutics SA. (5/20/26). "Press Release: HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis". Lausanne & San Diego, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]